effect of panchakarma treatment like virechana and basti in type 2 diabetes

To Evaluate the add on effect of Virechana followed by Basti on Mitochondrial Dysfunction assessed through Humanin in Patient of Type 2 Diabetes (Prameha) An open labelled Randomized Standard Controlled Clinical Trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086823

Enrollment

100

Registered

2025-05-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having three or more signs and symptoms of the disease. Freshly diagnosed patients and patient with ongoing medication (metformin/combination of metformin) of Type 2 Diabetes with blood sugar level- FBS - 126 to 220 mg/dl or PPBS - 200 to 300 mg/dl or Age group of 30-65 years. Patient fit for Virechana and Basti Karma.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Increase Sr. Humanin (HN) levelTimepoint: 4th week of treatment	—

Secondary

Measure	Time frame
Reduction the levels FBS & PPBS Improvement in the quality of Life in Diabetic Patients. Timepoint: 4th week of treatment	—

Countries

India

Contacts

Public ContactDevika Bhuva

ITRA Jamnagar

anup_Thakar@yahoo.com9427776660

Outcome results